{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicbxerqoeky2meca3pxa4jeq3la4whtuymlssrxprdxfwyhgqexb4",
    "uri": "at://did:plc:5v5xdyhb3zf74bcdmcnazkrk/app.bsky.feed.post/3mndfpmiofdn2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiaohjmm7t5nzskgimbjyyzlcer2btmwlni3xgk7dxr3jwtyef4g5u"
    },
    "mimeType": "image/jpeg",
    "size": 220032
  },
  "path": "/science/news-science/a-daily-pill-nearly-doubled-survival-for-the-worlds-deadliest-cancer/",
  "publishedAt": "2026-06-02T18:03:26.000Z",
  "site": "https://www.zmescience.com",
  "tags": [
    "Health",
    "News",
    "cancer treatment",
    "chemotherapy",
    "clinical trial",
    "daraxonrasib",
    "KRAS",
    "metastatic cancer",
    "oncology",
    "pancreatic cancer",
    "targeted therapy"
  ],
  "textContent": "The results were so promising one clinician started weeping.",
  "title": "A Daily Pill Nearly Doubled Survival for the World’s Deadliest Cancer"
}